FDA nanomaterial draft guidance means pointless extra regulation, say experts
FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.
FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.
Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.
Novavax is leasing a cGMP plant in Maryland under ‘very favourable terms’ to meet anticipated demand for its VLP vaccines.
ShangPharma is opening a 100,000 sq ft facility dedicated to serving a big customer as it continues to strengthen ties to top clients.
German technology giant Schott has signed an agreement with a Chinese firm to provide the fast-growing pharmaceutical market with a range of high-end glass packaging products.
The CRO industry is still considered a good long-term investment and the clinical services segment is set to continue its dominance thanks to sponsor R&D spending, says leading banker.